FDA Inspection 1068515 — Hunan Er-Kang Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hunan Er-Kang Pharmaceutical Co., Ltd. on Sep 21, 2018 in Liuyang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 21, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Liuyang (China)